CVS settles US Justice Department case over opioid prescriptions for $315 million

CVS Pharmacy and its subsidiaries agreed to pay a $315 million settlement to the Justice Department. This resolves a 2024 lawsuit alleging the company unlawfully dispensed medically unnecessary prescriptions of highly addictive opioids and other controlled substances to increase profits. The DOJ claims CVS improperly filled these prescriptions and sought reimbursement from federal healthcare programs. This settlement is part of a broader federal effort to hold companies accountable for their roles in the U.S. addiction and overdose crisis.